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Summary
A new biotechnological process for the production of
testosterone (TS) has been developed to turn the model
strain Mycobacterium smegmatis suitable for TS pro-
duction to compete with the current chemical synthesis
procedures. We have cloned and overexpressed two
genes encoding microbial 17b-hydroxysteroid: NADP
17-oxidoreductase, from the bacterium Comamonas
testosteroni and from the fungus Cochliobolus lunatus.
The host strains were M. smegmatis wild type and a
genetic engineered androst-4-ene-3,17-dione (AD) pro-
ducing mutant. The performances of the four recombi-
nant bacterial strains have been tested both in growing
and resting-cell conditions using natural sterols and
AD as substrates respectively. These strains were able
to produce TS from sterols or AD with high yields. This
work represents a proof of concept of the possibilities
that offers this model bacterium for the production of
pharmaceutical steroids using metabolic engineering
approaches.
Introduction
Testosterone (TS) is one of the oldest drugs used in
medicine and has a long efﬁcacy and safety record for
hormone replacement therapy in men with androgen
deﬁciency. Currently, TS is chemically produced from
androst-4-ene-3,17-dione (AD) (Ercoli and Ruggierii,
1953). In mammals, the synthesis of TS from AD is
catalysed by the microsomal 17-ketosteroid reductase
(17b-HSD; 17b-hydroxysteroid:NADP 17-oxidoreduc-
tase, EC 1.1.1.64) (Bogovich and Payne, 1980)
(Fig. 1). Up to now, 14 different subtypes of 17b-HSD
have been identiﬁed in mammals and most of them
belong to the short-chain dehydrogenase:reductase
superfamily (SDR). They catalyse NAD(P)H/NAD(P)+-
dependent reductions/oxidations at the C-17 position of
different steroids (Peltoketo et al., 1999; Moeller and
Adamski, 2006, 2009; Marchais-Oberwinkler et al.,
2011). The majority of 17b-HSD enzymes are able to
catalyse, at least to some extent, reverse reactions
under in vitro conditions. In the presence of a substan-
tial excess of a suitable cofactor and/or in the absence
of the preferred cofactor, 17b-HSD can be compelled
to catalyse both oxidative and reductive reactions.
Based on this property, a process has been developed
to produce in vitro TS from AD using the recombinant
murine 17b-HSD type V (aldo-keto-reductase instead
of SDR family) and glucose dehydrogenase as cofac-
tor recycling enzyme (Fogal et al., 2013). However,
due to the high cost of the process, it is not currently
used for industrial purposes.
On the other hand, enzymatic reduction of AD to TS
by 17b-HSD has also been described in different
microorganisms (Donova et al., 2005), including bacteria
(Schultz et al., 1977; Payne and Talalay, 1985; Sarmah
et al., 1989; Liu et al., 1994; Egorova et al., 2002a,b,
2005), yeasts (Ward and Young, 1990; Singer et al.,
1991; Długonski and Wilmanska, 1998; Pajic et al.,
1999), ﬁlamentous fungi (Kristan and Rizner, 2012) and
plants (Hamada and Kawabe, 1991). Moreover, a single-
step microbial transformation process has been reported
for the production of TS from sterols using several
Mycobacterium sp. mutants (Wang et al., 1982; Hung
et al., 1994; Liu et al., 1994; Llanes et al., 1995; Liu and
Lo, 1997; Borrego et al., 2000; Lo et al., 2002; Mei
et al., 2005; Egorova et al., 2009). During the course of
this work, Dlugovitzky et al. (2015) have shown that
Mycobacterium smegmatis PTCC 1307 was able to pro-
duce TS and other estrogens from tritiated precursors.
However, TS has not been detected as a metabolic
intermediate when M. smegmatis mc2155 is cultured in
the presence of phytosterols or cholesterol, neither in
the wild-type strain nor in the AD-producing strain (Galan
et al., unpublished), unlike in other mycobacterial spe-
cies (Wang et al., 1982; Smith et al., 1993; Egorova
et al., 2002b). This observation suggests that M. smeg-
matis mc2155 does not contain a functional gene encod-
ing a 17b-HSD or at least, it is not induced in the
presence of these compounds.
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Although several microbial 17b-HSD enzymes have
been cloned and characterized (Abalain et al., 1993;
Rizner et al., 1999; Chang et al., 2010), none of them
were used to develop genetically engineered bacteria to
improve the biotechnological production of TS. These
genes have been only expressed in Escherichia coli, a
bacterium unable to efﬁciently transport sterols or AD,
impairing the development of an industrial biotransforma-
tion processes.
The aim of this work was to develop recombinant bac-
teria overexpressing 17b-HSD genes that will be able to
efﬁciently biotransform either natural sterols (e.g. phytos-
terols or cholesterol) or AD into TS in order to compete
with the current chemical synthesis of TS by using a
new biotechnological process. To fulﬁl this goal, we have
cloned and overexpressed the genes encoding two
microbial 17b-HSDs, from the bacterium Comamonas
testosteroni (Abalain et al., 1993) and from the fungus
Cochliobolus lunatus (Rizner et al., 1999), using as
hosts the wild-type M. smegmatis and an AD-producing
mutant of this bacterium. The performances of the new
created recombinant bacterial strains have been tested
both in growing and resting-cell conditions using sterols
and AD as substrates respectively (Fig. 2).
Results and discussion
Working hypothesis and selection of 17b-HSD encoding
genes
Up to now, to our knowledge, there is not an example of
any engineered bacterium able to produce TS from ster-
ols or AD. In this sense, we decided to investigate if
ANDROST-4-ENE-3,17-DIONE (AD) TESTOSTERONE (TS)17β-HSD
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NAD(P)+NAD(P)H
Fig. 1. Schematic representation of
transformation process of AD into TS by
17b-HSD.
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Fig. 2. Methods for TS synthesis. (A) Current synthesis of TS at the pharmaceutical industry. First, biotransformation process for the production
of AD from sterols is carried out by Mycobacterium sp. Second, AD is transformed into TS by a chemical process. (B) Alternative production of
TS proposed in this work by recombinant M. smegmatis strains overexpressing 17b-HSD-encoding genes. The biotransformation of AD into TS
can be achieved by resting-cell in the strains M. smegmatis mc2155 (pHSDCT) and M. smegmatis mc2155 (pHSDCL). The production of TS
from sterols can be realized by growing-cell biotransformations in the mutant strains M. smegmatis MS60369-5941 (pHSDCT) and M. smegmatis
MS60369-5941 (pHSDCL).
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M. smegmatis could be a suitable chassis for this pur-
pose. The selection of M. smegmatis to achieve TS pro-
duction is mainly based in two properties: ﬁrst, it is not
able to degrade AD and second, there are evidences
that AD can be efﬁciently transported (L. Fernandez-
Cabezon et al., unpublished). Therefore, the circumven-
tion of the bacterial mineralization of AD and TS during
the biotransformation process is not a requirement. We
have already evidenced that this fast-growing and non-
pathogenic bacterium, which is able to transport and
metabolize cholesterol and phytosterols, can be a suit-
able cell factory for the industrial production of steroid
intermediates such as AD using sterols as feedstock
(Galan et al., unpublished). Other steroid-metabolizing
bacteria that are able to transport AD (e.g. Comamonas,
Rhodococcus or Gordonia) cannot be in principle used
as an alternative host because they degrade AD and TS
efﬁciently (Tamaoka et al., 1987; Cabrera et al., 2000;
Fernandez de las Heras et al., 2009; Li et al., 2014).
Taking into account that we were not able to identify in
M. smegmatis mc2155, a functional gene encoding a
17b-HSD, the aim of this work was to overproduce a
17b-HSD obtained from a heterologous organism either
in the wild-type or the AD-producing mutant strains. In
this way, the M. smegmatis recombinant strains can be
utilized to transform AD into TS by a resting-cell system
or to produce TS from sterols by a fermentation process
(Fig. 2).
As the genes encoding 17b-HSD enzymes from
mycobacterial species have not been identiﬁed and
these proteins have been only partially puriﬁed and
characterized (Goren et al., 1983; Egorova et al.,
2002a, 2005), we initially selected as enzyme candi-
dates for metabolic engineering the well-described 17b-
HSDs from the bacterium C. testosteroni (Schultz
et al., 1977; Lefebvre et al.,1979; Minard et al., 1985;
Genti-Raimondi et al., 1991; Yin et al., 1991; Abalain
et al., 1993; Benach et al., 1996, 2002; Oppermann
et al., 1997; Cabrera et al., 2000) and the fungus C.
lunatus (Plemenitas et al., 1988; Rizner et al., 1996,
1999, 2000, 2001a,b; Rizner and Zakelj-Mavric, 2000;
Zorko et al., 2000; Kristan et al., 2003, 2005, 2007a,b;
Cassetta et al., 2005; Ulrih and Lanisnik Rizner, 2006;
Brunskole et al., 2009; Svegelj et al., 2012), because
both enzymes present some relevant differences.
Although they catalyse a reversible reaction and dis-
play similar reaction mechanisms, the reaction equilib-
rium of the fungal 17b-HSD is shifted towards
reduction, whereas the bacterial enzyme is shifted
towards oxidation, as this enzyme is mainly involved
into the TS catabolism in C. testosteroni (Genti-Rai-
mondi et al., 1990; Cabrera et al., 2000). Moreover,
the fungal 17b-HSD prefers NADPH as coenzyme for
reduction of AD, while preferences between NAD+/
NADP+ are not observed for oxidation of TS (Rizner
and Zakelj-Mavric, 2000). The bacterial enzyme is in
fact a 3b/17b-HSD, this is a bifunctional enzyme with
a single catalytic site able to accommodate both the
3b- and 17b-activities, and uses NAD(H) as cofactor
(Minard et al., 1985; Benach et al., 2002). These
issues are relevant for developing a biotechnological
process as the cellular content of NAD(H) and/or
NADP(H) will determine the direction of the catalytic
reaction and the yield of TS production. Remarkably,
Xu et al. (2016) have described the Hsd4A protein of
M. neoaurum ATCC 25795 as a dual-function enzyme,
with both 17b-HSD and b-hydroxyacyl-CoA dehydroge-
nase activities in vitro. However, the 17b-HSD enzyme
does not appear to be reversible in vitro as it is able
to transform TS into AD but not AD into TS (Xu et al.,
2016).
As an alternative to the 17b-HSD enzymes of
C. testosteroni and C. lunatus, we have tried to identify
homologous enzymes in other microorganisms. For
instance, we found mycobacterial proteins with a small
identity (<40%) to the 17b-HSD enzyme from C. testoter-
oni. In particular, several putative homologue short-chain
dehydrogenases were found in M. smegmatis mc2155,
such as the 3-a-(or 20-b)-hydroxysteroid dehydrogenase
(MSMEG_3515, 38% identity), and the cyclopentanol
dehydrogenase (MSMEG_6709, 37% identity). Analysing
the genomic context of such genes, non-relationship with
steroid degradative enzymes was found. On the other
hand, the 17b-HSD from C. lunatus presents a high
sequence identity (60–95%) with proteins from the fungal
Leotiomyceta group, which belongs to Ascomycota Phy-
lum. These identities are not present in other representa-
tives of this phylum, such as the Saccharomyces genus.
However, 17b-HSD activity was detected in Saccha-
romyces cerevisiae and other fungi (Ward and Young,
1990; Długonski and Wilmanska, 1998). Outside Leo-
tiomyceta group, identities of 42–48% are found in bac-
teria of different phyla (Cyanobacteria, different groups
of Proteobacteria, Firmicutes, etc.), including members
of actinobacteria (e.g. Mycobacterium abscessus,
Rhodococcus wratislaviensis NBRC 100605 or several
Streptomyces species). In M. smegmatis, only proteins
with an identity lower than 36% are found. Consequently,
the correlation between protein identity and 17 b-HSD
activity, as well as their true biological role in the native
organisms, cannot be easily established by in silico
analysis. In fact, this observation has been also
described in vertebrates whose 17 b-HSD enzymes
show generally low sequence similarity (15–20%) (Moel-
ler and Adamski, 2009). Therefore, on the light of these
analyses, ﬁnally the 17b-HSD enzymes from C. testos-
teroni and C. lunatus were selected as the best choice
to carry out our work.
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Engineering heterologous 17b-HSDs in recombinant M.
smegmatis strain
We have cloned the genes encoding the 17 b-HSDs
from C. testosteroni and C. lunatus in pMV261, an
E. coli/M. smegmatis shuttle vector, under the control
of the constitutive Phsp60 promoter, rendering the
plasmids pHSDCT and pHSDCL respectively (see
Experimental procedures). Both plasmids were trans-
formed in both, the M. smegmatis wild-type strain
and the AD-producing M. smegmatis MS6039-5941
mutant, generating four recombinant strains, i.e. M.
smegmatis mc2155 (pHSDCT), M. smegmatis mc2155
(pHSDCL), M. smegmatis MS6039-5941 (pHSDCT)
and M. smegmatis MS6039-5941 (pHSDCL)
(Table 1).
Production of TS from AD by resting-cell
biotransformation
The ability of the M. smegmatis (pHSDCT) and
M. smegmatis (pHSDCL) recombinant strains to pro-
duce TS from AD was tested using a resting-cell
assay. In the standard conditions (no additional carbon
sources present in the reaction medium), small amount of
TS was detected (Fig. 3). However, when the reaction
medium was supplemented with 1% glucose, the sub-
strate AD was efﬁciently transformed into TS using both
strains (Fig. 3). The biotransformation was slightly more
efﬁcient using the recombinant bacteria harbouring the
fungal gene [i.e. M. smegmatis (pHSDCL)]. When the
reaction medium was supplemented with 1% glycerol
instead of glucose, the biotransformation was slightly less
efﬁcient (Fig. 3). This result suggest that the intracellular
NAD(P)+/NAD(P)H ratio could be different in the presence
of glucose or glycerol being critical for the process. In this
sense, the effect of a carbon source supplementation and
also the pH have been already demonstrated to be deter-
minant in the reaction equilibrium for the TS production
(Liu et al., 1994; Llanes et al., 1995; Liu and Lo, 1997;
Egorova et al., 2009).
The use of the recombinant M. smegmatis MS6039-
5941 (pHSDCT) and M. smegmatis MS6039-5941
(pHSDCL) strains instead the wild-type recombinants
does not provide any signiﬁcant advantage in the rest-
ing-cell process because, as mentioned above, both the
wild-type and MS6039-5941 mutant strains are unable to
metabolize AD or TS.
Table 1. List of bacterial strains, plasmids and primers used in this study.
Strains or plasmids Genotype and/or description Source or reference
Strains
Mycobacterium "smegmatis
mc2155 ept-1, mc²6 mutant efﬁcient for electroporation Snapper et al. (1990)
MS6039-5941 mc2155 mutant DMSMEG_6039 DMSMEG_5941 Galan et al. (unpublished)
mc2155 (pHSDCT) mc2155 harbouring plasmid pHSDCT This study
mc2155 (pHSDCL) mc2155 harbouring plasmid pHSDCL This study
MS6039-5941(pHSDCT) MS6039-5941 harbouring plasmid pHSDCT This study
MS6039-5941(pHSDCL) MS6039-5941 harbouring plasmid pHSDCL This study
Escherichia coli This study
DH10B F, mcrA, D (mrrhsdRMS-mcrBC), Φ80dlacZDM15, DlacX74, deoR,
recA1, araD139, D(ara-leu)7697, galU, galK, k, rpsL, endA1, nupG
Invitrogen
DH10B (pUC57-17HSD) DH10B strain harbouring plasmid pUC57-17HSD This study
DH10B (pGEMT-HSDCT) DH10B strain harbouring plasmid pGEMT-HSDCT This study
DH10B (pHSDCT). DH10B strain harbouring plasmid pHSDCT This study
Comamonas testosteroni
ATCC 11996TM ATCC
Plasmids
pMV261 Mycobacterium/E. coli shuttle vector with the kanamycin resistance aph
gene from transposon Tn903 and the promoter from the hsp60 gene
from M. tuberculosis
Stover et al. (1991)
pGEM-T Easy E. coli cloning vector; AmpR; T7 and SP6 RNA polymerase promoters
ﬂanking a multiple cloning
region within the a-peptide coding region of
b-galactosidase for the identiﬁcation of recombinants by blue/white screening
Promega
pGEMT-HSDCT pGEMT-Easy harbouring the gene encoding the 17b-HSD from C. testosteroni This study
pUC57-17HSD pUC57 harbouring the synthetic gene encoding the 17b-HSD from C. lunatus This study
pHSDCT pMV261 harbouring the gene encoding the 17b-HSD from C. testosteroni This study
pHSDCL pMV261 harbouring the synthetic gene encoding the 17b-HSD from C. lunatus This study
Primers
HDHF AGAGGAGATATACCATGGGCAGCAGCCATCATCATCATCATCACACAAATCG
TTTGCAGGGTAAGG
This study
HDHR AAGCTTCTATAGCCC
CATGCCCAGAATCG
This study
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Production of TS from sterols by growing-cells
biotransformation
The ability to produce TS from natural sterols in a single
biotransformation step was tested by growing M. smeg-
matis MS6039-5941 (pHSDCT) and M. smegmatis
MS6039-5941 (pHSDCL) strains in minimal medium con-
taining 18 mM glycerol as a main carbon and energy
source and 1.8 mM cholesterol as a substrate. In this
culture condition, the two recombinant strains trans-
formed the cholesterol into AD but TS was only detected
in small traces during the exponential growth phase
(Fig. 4). Based on the resting-cell results, we tested the
production of TS from sterols using 9 mM glucose
instead of 18 mM glycerol as a carbon source obtaining
similar results those using glycerol (data not shown). It is
worth to mention that, in this culture condition, cell
growth is only observed during the ﬁrst 24 h due to the
complete consumption of glycerol or glucose. After this
time, the cholesterol is still transformed into AD but the
cholesterol side-chain degradation might not supply
enough carbon and/or energy to support cell division
(Fig. 4). Moreover, the reduction of AD into TS is not
efﬁcient in nutrient-limited conditions and an alternative
carbon source could be necessary for reactivating cell
metabolism.
As the biotransformation of AD into TS appears to be
dependent of the NAD(P)/NAD(P)H cofactor balance, we
simulated a pseudo-resting-cell system carrying out two
consecutive biotransformation steps at the same shake
ﬂask. The ﬁrst step was carried out in the presence of
18 mM glycerol and 1.8 mM cholesterol. In these
conditions, we have observed that the cholesterol is
mostly depleted and transformed into AD before 69 h of
culture (data not shown). So at this moment, in a second
step, we added glucose or glycerol and measured the
production of TS after 24 h as it was done for the rest-
ing-cell assays. Using this approach, the two recombi-
nant strains were able to transform sterols into TS more
efﬁciently, although signiﬁcant differences were observed
probably due to kinetic differences between both 17b-
HSD enzymes (Fig. 5). In the presence of 1% glucose,
the average rate of TS to androstenes (AD and TS) was
77.6% and 28.6% using the strains MS6039-5941
(pHSDCL) and MS6039-5941 (pHSDCT) respectively.
Similar results were obtained when glucose was used as
an initial carbon source and glucose was added at 69 h
of culture (data no shown). However, this average rate
was slightly lower when an addition of glycerol instead of
glucose was supplied to both strains (Fig. 5).
To test the inﬂuence of bacterial metabolic state on
the TS production, other culture conditions were
assayed. First, we tested the addition of glucose at the
late-exponential growth phase (e.g. 23.5 h) (Fig. 6). Sec-
ond, we added higher concentrations of carbon source
at the beginning of the culture (e.g. 55.5 mM glucose
(1% glucose) instead of 18 mM glycerol) (Fig. 6). In both
culture conditions, the recombinant strains were able to
produce TS from cholesterol but their behaviour was dif-
ferent. The strain MS6039-5941 (pHSDCL) produced
higher TS yields and the reversion of TS to AD was not
signiﬁcant. However, the strain MS6039-5941 (pHSDCT)
produced TS but in this case a notable reconversion of
TS into AD was observed after 47 h of culture. The
molar conversion rates and the TS to androstenes ratios
are shown in Fig. 7. According to these results, the pro-
duction of TS from sterols is achieved more efﬁciently
0%
20%
40%
60%
80%
100%
1 2
M
ol
ar
 c
on
ve
rs
io
n 
ra
te
Fig. 3. Production of TS by resting-cell processes. The conversion
of AD by the strains Mycobacterium smegmatis mc2155 (pHSDCT)
(1) and M. smegmatis mc2155 (pHSDCL) (2) was tested in three
culture conditions: no carbon source addition (blue), 1% glucose
(red) and 1% glycerol (green). Average and standard deviation of
two biological replicates at 24 h of culture are represented.
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Fig. 4. Production of TS from cholesterol by growing-cell processes.
The strains Mycobacterium smegmatis MS6039-5941 (pHSDCT)
(red) and M. smegmatis MS6039-5941 (pHSDCL) (blue) were
growth at minimal medium containing 18 mM glycerol (carbon and
energy source) and 1.8 mM cholesterol (substrate). The AD concen-
tration (continuous lines) and TS (dashed lines) and DO600 (dotted
line) are represented. A representative experiment is shown.
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with the strain MS6039-5941 (pHSDCL) than with the
strain MS6039-5941 (pHSDCT). Although the presence
of an additional carbon source (i.e. glycerol or glucose)
is required for the production of TS for both recombinant
strains, the reconversion of TS into AD is not observed
in the case of the fungal 17b-HSD-expressing strain
once the carbon source has been consumed. This
reversibility was described previously in other mycobac-
terial mutants producing TS from cholesterol (Liu and
Lo, 1997). These results reinforce the use of the fungal
enzyme as the best candidate to genetically engineer
the recombinant strains to produce TS from sterols.
Concluding remarks
We have demonstrated that M. smegmatis is an excel-
lent chassis to develop biotechnological processes for
the biotransformation of sterols and their derivatives into
valuable pharmaceutical compounds. The current
genetic tools available to transform this organism have
allowed for expressing stably two genes coding 17b-
HSDs enzymes. Our recombinant strains were able to
produce TS from AD and/or from sterols with high yields
that are comparable with previously published data using
mycobacterial strains obtained by conventional mutation
procedures (Liu et al., 1994; Liu and Lo, 1997). More-
over, our rational approach makes possible the introduc-
tion of heterologous 17b-HSD enzymes from diverse
origins with different catalytic properties (e.g., substrate
and cofactor speciﬁcity) offering more versatility than
conventional methods. Some of the 17b-HSD activities
described in the conventional mutants appears to have
different catalytic properties. In fact, in some mycobacte-
rial strains, the double reduction of ADD [both of 17-keto
group and 1(2)-double bound] was more effective for TS
formation than a single reduction of 17-keto group of AD
(Hung et al., 1994; Egorova et al., 2009).
This work represents a proof of concept of the possi-
bilities of using this model bacteria and metabolic engi-
neering approaches for the production of pharmaceutical
steroids. However, additional efforts are needed to opti-
mize the production of TS from sterols in a single bio-
transformation step. Two factors appear to be
determinant for the improvement of this process: the
reversibility of 17b-HSD enzymes and the cell metabolic
state. To overcome the ﬁrst of these factors, works to
identify non-reversible 17b-HSDs and/or to modify the
characterized enzymes by protein engineering can be
explored. Several in vitro attempts have been already
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Fig. 5. Production of TS from cholesterol by a pseudo-resting-cell
process. The strains Mycobacterium smegmatis MS6039-5941
(pHSDCT) and M. smegmatis MS6039-5941 (pHSDCL) were growth
at minimal medium containing 18 mM glycerol (carbon and energy
source) and 1.8 mM cholesterol (substrate) and, 1% glucose or
glycerol was added at 69 h of culture. The following cultures were
tested: MS6039-5941 (pHSDCT) with glucose (red); MS6039-5941
(pHSDCT) with glycerol (orange); MS6039-5941 (pHSDCL) with glu-
cose (blue) and MS6039-5941 (pHSDCL) with glycerol (green). The
AD concentration (continuous lines) and TS (dashed lines) are rep-
resented. A representative experiment is shown.
0.0
0.3
0.6
0.9
1.2
0 20 40 60 80
C
on
ce
nt
ra
tio
n 
(m
M
) 
Time of culture (h)
0.0
0.3
0.6
0.9
1.2
0 20 40 60 80
C
on
ce
nt
ra
tio
n 
(m
M
) 
Time of culture (h)
(A)
(B)
Fig. 6. Production of TS from cholesterol by growing-cell processes.
The Mycobacterium smegmatis MS6039-5941 (pHSDCT) (red) and
M. smegmatis MS6039-5941 (pHSDCL) (blue) strains were grown in
minimal medium containing 1.8 mM cholesterol (substrate) and an
alternative carbon source: (A) 18 mM glycerol with an addition of
1% glucose at 24 h; (B) 1% glucose without any addition The AD
concentration (continuous lines) and TS (dashed lines) are repre-
sented. A representative experiment is shown
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done to design rationally 17b-HSD mutants from C.
testosteroni and C. lunatus which present alterations in
substrate speciﬁcity and/or coenzyme requirements, as
well as improvements overall catalytic activity (Opper-
mann et al., 1997; Kristan et al., 2003, 2005, 2007a,b;
Brunskole et al., 2009; Svegelj et al., 2012). To over-
come the second factor, the control of bacterial metabo-
lism by metabolic engineering and systems biology
approaches would be useful. Factors such as the sup-
plementation of carbon source, pH or mode of substrate
addition, have been proved to be determinant for the
reduction of AD to TS. Systems biology approaches
could give more detailed information about microbial
metabolism and how to increase TS yields.
Experimental procedures
Chemicals
4-Androstene-3,17-dione (AD) was purchased from TCI
America. Chloroform, glucose and glycerol were pur-
chased from Merck (Darmstardt, Germany). Methanol
and acetonitrile of HPLC quality were purchased from
Scharlau (Sentmenat, Spain). Cholesterol, TS, Tween
80, tyloxapol, ampicilin and kanamycin were from Sigma
(Steinheim, Germany).
Bacterial strains, plasmids and culture conditions
The bacterial strains, plasmids and primers used in this
work are listed in Table 1. Mycobacterium smegmatis
strains were grown at 37°C in an orbital shaker at
200 rpm. Middlebrook 7H9 broth medium (Difco) supple-
mented with 0.4% glycerol and 0.05% Tween 80 was
used as rich medium. 7H9 broth without any supplement
was used as minimal medium. 7H10 agar (Difco) plates
supplemented with 10% albumin-dextrose-catalase (Bec-
ton Dickinson) were used for solid media. Kanamycin
(20 lg ml1) was used for strain selection when appro-
priate.
Escherichia coli DH10B strain was used as host for
cloning purposes. It was grown in LB medium at 37°C in
an orbital shaker at 200 rpm. LB agar plates were also
used for solid media. Ampicilin (100 lg ml1) or kana-
mycin (50 lg ml1) were used for plasmid selection and
maintenance.
Comamonas testosteroni ATCC 11996 was grown in
LB medium at 30°C in an orbital shaker at 200 rpm to
extract genomic DNA.
DNA manipulations and sequencing
DNA manipulations and other molecular biology tech-
niques were essentially as described by Sambrook and
Russell (2001). Isolation of C. testosteroni genomic DNA
was performed with the Bacteria Genomic Prep Mini
Spin Kit (GE Healthcare). Oligonucleotides were pur-
chased from Sigma-Aldrich. DNA ampliﬁcation was per-
formed on a Mastercycler Gradient (Eppendorf) using
DNA polymerase I and Pfu polymerase from Biotools B.
M. Labs. Reaction mixtures contained 1.5 mM MgCl2
and 0.25 mM dNTPs. DNA fragments were puriﬁed with
High Pure PCR System Product Puriﬁcation Kit (Roche).
Restriction enzymes were obtained from various suppli-
ers and were used according to their speciﬁcations.
Plasmid DNA was prepared with a High Pure Plasmid
Isolation Kit (Roche Applied Science). Escherichia coli
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Fig. 7. Conversion rates of TS in growing-cell processes. The strains Mycobacterium smegmatis MS6039-5941 (pHSDCT) (red bars) and M.
smegmatis MS6039-5941 (pHSDCL) (blue bars) were grown at minimal medium containing 1.8 mM cholesterol (substrate) and 18 mM glycerol
(carbon and energy source). The following culture conditions were tested: (A) Without addition of any carbon source; (B) with addition of 1%
glucose at 24 h; (C) with addition of 1% glucose at 69 h; (D) with addition of 1% glycerol at 69 h; (E) without addition and 1% glucose instead
of glycerol as initial substrate. The molar conversion rate of TS (ﬁrst and second bars) and the ratio of TS to androstenes (third and fourth bars)
at the end of the culture (93 h) are shown. The molar conversion rate was calculated on the basis of 1.8 mM cholesterol added. Androstenes
are calculated by adding AD and TS. Average and standard deviation of two biological replicates are represented.
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was transformed by the rubidium chloride method (Wirth
et al., 1989). Mycobacterium smegmatis cells were
transformed by electroporation (Gene Pulser; Bio-Rad)
(Parish and Stoker, 1998). All cloned inserts and
DNA fragments were conﬁrmed by DNA sequencing
through an ABI Prism 377 automated DNA sequencer
(Applied Biosystems Inc.) at Secugen S.L. (Madrid,
Spain).
Construction of plasmids pHSDCT and pHSDCL
To isolate the gene encoding the 3b/17b-HSD from C.
testosteroni ATCC 11996, the genomic DNA was iso-
lated and ampliﬁed the gene by PCR using the oligonu-
cleotides HDHF and HDHR (Table 1). A sequence
coding six histidines was inserted in the oligonucleotide
HDHF, generating a novel gene version encoding a
modiﬁed 17b-HSD from C. testosteroni that contains a
polyhistidine-tag inserted in the N-terminal end. The
ampliﬁed 812 bp fragment was cloned into pGEM-T
Easy (Promega) to generate the plasmid pGEMT-
HSDCT using E. coli DH10B as host. The cloned frag-
ment was further subcloned into the plasmid pMV261
able to replicate in E. coli and Mycobacterium. For this
goal, the plasmid pGEMT-HSDCT was digested with
EcoRI and HindIII and the fragment was ligated with the
vector pMV261 cut with the same restriction enzymes
generating the plasmid pHSDCT. This plasmid was
transformed into E. coli DH10B to generate the recombi-
nant strain E. coli DH10B (pHSDCT). The plasmid
pHSDCT isolated from E. coli was transformed by
electroporation into M. smegmatis mc2155 and the
AD-producing mutant M. smegmatis MS6039-5941
competent cells, generating the recombinant strains
M. smegmatis mc2-155 (pHSDCT) and M. smegmatis
MS6039-5941 (pHSDCT) (Table 1).
The gene encoding the 17b-HSD from C. lunatus
was chemically synthesized with an optimized codon
usage for its expression in Mycobacterium (ATG:
biosynthetics GmbH, Germany) (Fig. 8). The codon
optimization was carried out using the program OPTI-
MIZER (Puigbo et al., 2007) and the codon usage
table found in KDRI (Kazusa DNA Research Institute,
Japan). The synthetic gene was supplied cloned into
the EcoRV site of the commercial vector pUC57 gen-
erating the plasmid pUC57-17HSD. This plasmid was
transformed into E. coli DH10B generating the recom-
binant strain E. coli DH10B (pUC57-17HSD). The frag-
ment containing the synthetic gene encoding the
17b-HSD was subcloned into the plasmid pMV261. For
this purpose, the pUC57-17HSD plasmid was digested
with EcoRI and HindIII and the fragment was ligated
to the pMV261 vector digested with the same restric-
tion enzymes. Thus, we created the plasmid pHSDCL
which was transformed into E. coli DH10B to generate
the recombinant E. coli DH10B (pHSDCL). The plas-
mid pHSDCL extracted from E. coli was transformed
by electroporation into M. smegmatis mc2155 and M.
smegmatis MS6039-5941 competent cells to generate
the recombinant strains M. smegmatis mc2155
(pHSDCL) and M. smegmatis MS6039-5941 (pHSDCL)
respectively.
CGGGATCCCGGAATTCTGACCTAAGGAGGTGAATCATATGCCGCACGTGG
AGAACGCCTCGGAGACCTACATCCCGGGCCGCCTGGACGGCAAGGTGGCC
CTGGTGACCGGCTCGGGCCGCGGCATCGGCGCCGCCGTGGCCGTGCACCT
GGGCCGCCTGGGCGCCAAGGTGGTGGTGAACTACGCCAACTCGACCAAGG
ACGCCGAGAAGGTGGTGTCGGAGATCAAGGCCCTGGGCTCGGACGCCATC
GCCATCAAGGCCGACATCCGCCAGGTGCCGGAGATCGTGAAGCTGTTCGA
CCAGGCCGTGGCCCACTTCGGCCACCTGGACATCGCCGTGTCGAACTCGG
GCGTGGTGTCGTTCGGCCACCTGAAGGACGTGACCGAGGAGGAGTTCGAC
CGCGTGTTCTCGCTGAACACCCGCGGCCAGTTCTTCGTGGCCCGCGAGGC
CTACCGCCACCTGACCGAGGGCGGCCGCATCGTGCTGACCTCGTCGAACA
CCTCGAAGGACTTCTCGGTGCCGAAGCACTCGCTGTACTCGGGCTCGAAG
GGCGCCGTGGACTCGTTCGTGCGCATCTTCTCGAAGGACTGCGGCGACAA
GAAGATCACCGTGAACGCCGTGGCCCCGGGCGGCACCGTGACCGACATGT
TCCACGAGGTGTCGCACCACTACATCCCGAACGGCACCTCGTACACCGCC
GAGCAGCGCCAGCAGATGGCCGCCCACGCCTCGCCGCTGCACCGCAACGG
CTGGCCGCAGGACGTGGCCAACGTGGTGGGCTTCCTGGTGTCGAAGGAGG
GCGAGTGGGTGAACGGCAAGGTGCTGACCCTGGACGGCGGCGCCGCCTAA
CCC C
Fig. 8. Gene sequence encoding the 17b-
HSD from C. lunatus chemically
synthesized with an optimized codon usage
for its expression in Mycobacterium. The
ribosome-binding site (RBS), start codon
and stop codon are underlined. Several
recognition sites by restriction enzymes
were incorporated to facilitate subcloning
tasks.
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Resting-cell biotransformations
The recombinant strains were grown in rich medium at
37°C during 24 h. The cells were harvested by centrifu-
gation at 50009g for 20 min at 4°C and washed once
with 0.85% NaCl. The biotransformation was carried out
with an optical density (OD600) of 18 in a 100 ml shake
ﬂask containing 40 ml of reaction mixture: 0.1 M phos-
phate buffer (pH 8.0), 2 mM AD (substrate) and 0.05%
Tween 80. An additional carbon source was added in
some cases. AD was incorporated into the medium as a
solution with randomly methylated b-cyclodextrin (1:10.3,
molar ratio) (Klein et al., 1995).
Growing-cell biotransformations
The precultures of the recombinant strains were grown
in rich medium at 37°C during 24 h and used to inoc-
ulate 30 ml of 7H9 minimal medium containing 1.8 mM
cholesterol (substrate), 18 mM glycerol (carbon and
energy source), 3.6% tyloxapol and 20 lg ml1 kana-
mycin. Different concentrations of glucose instead of
glycerol were also tested. The cholesterol was dis-
solved in 10% tyloxapol prior to its addition to the min-
imal medium. Due to the low solubility of this steroid,
a stock solution was warmed at 80°C in agitation,
sonicated in a bath for 1 h and then autoclaved. The
cultures were grown in 100 ml shake ﬂasks at 37°C in
an orbital shaker at 200 rpm. An addition of 1% glu-
cose or 1% glycerol was added at different times of
culture.
Analytical methods
The culture broth was extracted with chloroform (0.5:1,
v/v) twice. The organic phase was evaporated and the
residue was dissolved in acetonitrile. AD and TS were
determined by reversed-phase HPLC using a Teknok-
roma mediterraneaTM Sea18 column (15 cm 9 0.46 cm;
5 lM) and UV detection at 240 nm. Mobile phase was
composed of methanol and water (75/25, v/v), ﬂow rate
0.85 ml min1. AD and TS were used as standards. The
conversion rate of TS was calculated on the basis of
cholesterol added to the medium (growing-cell biotrans-
formations) or AD measured into the sample (resting-cell
biotransformations).
Bioinformatic analysis
Sequence alignments were carried out using CLUSTAL W
(Thompson et al., 1994) and different BLAST algorithms
from the National Centre of Biotechnology Information
Server (NCBI) were also used.
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